Status:
RECRUITING
Mobile Health Technology for Personalized Tobacco Cessation Support in Laos
Lead Sponsor:
University of Oklahoma
Collaborating Sponsors:
Setthathirath Hospital
Champasak Hospital, Lao PDR
Conditions:
Cigarette Smoking
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
In Lao People's Democratic Republic (Lao PDR), 51% of adult men and 7% of adult women smoke tobacco. The development and evaluation of sustainable tobacco cessation interventions suitable for widespre...
Detailed Description
R21 Phase: Adaption of the AT intervention content In stage 1, formative research, including literature searches, quantitative results, and qualitative methods (e.g., key informant interviews) are of...
Eligibility Criteria
Inclusion
- (pilot RCT in the R21 Phase and main RCT in the R33 Phase):
- aged ≥18 years
- self-reported current combustible cigarette smokers (smoked at least 100 cigarettes in lifetime and currently smoke ≥1 cigarette/day)
- willing to set a quit date within 2 weeks of study enrollment
- able to provide written informed consent to participate
- able to read Lao (score ≥4 points on the Rapid Estimate of Adult Literacy in Medicine-Short Form).
Exclusion
- (pilot RCT in the R21 Phase and main RCT in the R33 Phase)
- history of a medical condition that precludes use of NRT
- ineligibility to participate based on medical or psychiatric conditions diagnosed by a physician/clinician
- enrollment in another cessation program or current use of other cessation medications.
Key Trial Info
Start Date :
April 27 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05233228
Start Date
April 27 2022
End Date
August 31 2026
Last Update
August 15 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Champasak Hospital
Champasak, Laos
2
Setthathirath Hospital
Vientiane, Laos